Candida Glabrata: An emerging threat for the Immunocompromised (original) (raw)
Loss of in vitro resistance in Candida glabrata following discontinuation of fluconazole prophylaxis in a hematopoietic stem cell transplantation patient
Cesar Freytes
Medical Mycology, 2010
View PDFchevron_right
Susceptibility of Candida species isolated from immunocompromised patients to antifungal agents
Satadal Das
2011
View PDFchevron_right
Candida glabrata: Review of Epidemiology, Pathogenesis, and Clinical Disease with Comparison to C. albicans
Jose Vazquez
1999
View PDFchevron_right
European Confederation of Medical Mycology (ECMM) prospective survey of candidaemia: report from one Italian region
Emanuela Biraghi
Journal of Hospital Infection, 2002
View PDFchevron_right
Epidemiology of Invasive Candidiasis and Challenges for the Mycology Laboratory: Specificities of Candida glabrata
célia pais
Curr Clin Micro Rpt, 2014
View PDFchevron_right
Prospective Study of Candida Species in Patients at a Comprehensive Cancer Center
David Perlin
Antimicrobial Agents and Chemotherapy, 2001
View PDFchevron_right
Distribution and antifungal susceptibility of Candida species in patients with increased risk for fungal infections
Maja Jurhar Pavlova
Macedonian Pharmaceutical Bulletin
View PDFchevron_right
A 3-year study of Candida infections among patients with malignancy: etiologic agents and antifungal susceptibility profile
Parisa Badiee
Frontiers in Cellular and Infection Microbiology, 2023
View PDFchevron_right
The Relative Frequency and Susceptibility Patterns of Candida Species Isolated from Blood and Urine of Children with Malignancy
Parisa Badiee
Archives of Pediatric Infectious Diseases, 2018
View PDFchevron_right
Sensitivity of Candida species in untreated patients
OSCAR G PAMO REYNA
View PDFchevron_right
The Epidemiology of Hematogenous Candidiasis Caused by Different Candida Species
motaz kabadaya
Clinical Infectious Diseases, 1997
View PDFchevron_right
Candida guilliermondii Fungemia in Patients with Hematologic Malignancies
Elisabetta Spreghini
Journal of Clinical Microbiology, 2006
View PDFchevron_right
Distribution and antifungal susceptibility of Candida species causing candidemia from 1996 to 1999
James Mwansa
Diagnostic Microbiology and Infectious Disease, 2004
View PDFchevron_right
Epidemiology and antifungal susceptibility of Candida species isolated from blood: results of a 2-year multicentre study in Spain
Mario Calvo
European Journal of Clinical Microbiology & Infectious Diseases, 2004
View PDFchevron_right
Clinical and Microbiological Characteristics of Candidemia Cases in Saudi Arabia
Amani Alnimr
Infection and Drug Resistance, 2023
View PDFchevron_right
Prevalence and Antifungal Susceptibility of 442 Candida Isolates from Blood and Other Normally Sterile Sites: Results of a 2-Year (1996 to 1998) Multicenter Surveillance Study in Quebec, Canada
Michel Laverdière, Michael Libman
Journal of Clinical Microbiology, 2001
View PDFchevron_right
Identification and Anti-Fungal Resistance Profile of Different Candida Species Isolated from Patients in ICUs
Dina Atef
International Journal of Current Microbiology and Applied Sciences, 2019
View PDFchevron_right
The changing epidemiology of invasive candidiasis: Candida glabrata and Candida krusei as the leading causes of candidemia in hematologic malignancy
Ying Jiang
Cancer, 2008
View PDFchevron_right
Species Distribution and Antifungal Susceptibility Profile of Candida Isolated in Various Clinical Samples at a Tertiary Care Centre
International Journal of Health Sciences and Research (IJHSR)
https://www.ijhsr.org/IJHSR\_Vol.6\_Issue.3\_March2016/10.pdf, 2016
View PDFchevron_right
Typing of Candida species isolated from blood cultures and analysis of their in vitro antifungal susceptibilities
Şenel YURTSEVER
African Journal of Microbiology Research, 2013
View PDFchevron_right
Role of Candida glabrata as nosocomial pathogen and its susceptibility to Fluconazole, Voriconazole, Caspofungin, Micafungin and Amphotericin B
mohammed kadhom
Bionatura
View PDFchevron_right
Prospective, Multicenter Surveillance Study of Candida glabrata: Fluconazole and Itraconazole Susceptibility Profiles in Bloodstream, Invasive, and Colonizing Strains and Differences between Isolates from Three Urban Teaching Hospitals in New York City (Candida Susceptibility Trends Study, 1998 t...
David Perlin
Antimicrobial Agents and Chemotherapy, 2002
View PDFchevron_right
Antifungal Susceptibility and Risk Factors in Patients with Candidemia
Fatma Bozkurt
The Eurasian Journal of Medicine, 2016
View PDFchevron_right
Frequency and Antifungal Susceptibility Pattern of Candida Species Causing Candidemia in Bone Marrow Transplant Unit
Anam Imtiaz
Pharmaceutical and Biosciences Journal
View PDFchevron_right
Effect of initial antifungal therapy on mortality among patients with bloodstream infections with different Candida species and resistance to antifungal agents: A multicentre observational study by the Turkish Fungal Infections Study Group
Süda Tekin
International Journal of Antimicrobial Agents, 2020
View PDFchevron_right
Distribution of Candida Species amongst Various Clinical Samples from Immunocompromised Patients attending Tertiary Care Hospital, Assam
Purnima Barua
International Journal of Current Microbiology and Applied Sciences, 2018
View PDFchevron_right
Nosocomial fungal infections: candidemia
Andreas Voss
Diagnostic Microbiology and Infectious Disease, 1999
View PDFchevron_right
The Effect of initial antifungal therapy on fatality among the patients with Blood Stream Infections with different Candida species and resistance to antifungal agents: A multicenter observational study of the Turkish Fungal Infections Study Group
Suzan Şahin
International Journal of Antimicrobial Agents, 2020
View PDFchevron_right